INSIGHTS ON CRITICAL ENVIRONMENTS

• Enable Modular, Plug‑And‑Produce Manufacturing

  Module Type Package enables plug‑and‑produce manufacturing through standardized interfaces. It simplifies integration, reduces engineering effort, and helps manufacturers reconfigure production.

• USP Draft Chapters On CCS: What You Need To Know

  Learn why it's important to stay aligned with evolving Annex 1 expectations to support sterility assurance, regulatory compliance, and patient safety across sterile drug manufacturing operations.

• Cleanroom Changes In 2026 For Better Contamination Control

  Proactively improve your cleanroom strategy for 2026. Gain actionable insights on leveraging Environmental Monitoring data, optimizing personnel, and managing residue to enhance contamination control.

• Digital Enhancements For Operational Excellence

  Unlock operational excellence with digital enhancements. Discover practical strategies to reduce errors, streamline processes, and drive continuous improvement across industries.

• Use Of Conductivity As A Tool For On-Site Residue Management

  3/7/2025

  Residues from cleaning and disinfection are under increased scrutiny in cleanrooms. A new method using conductivity measurements offers a more accurate and objective way to quantify these residues.

• Characteristics Of Environmental Residues And Protocols For Removal

  4/1/2025

  Examine disinfectant residue characteristics, impacts, and removal challenges in cleanrooms, as well as learn about the practical requirements for maintaining cleanliness standards and addressing these residues effectively.

• Ingredients In Small Molecule Drug Production Systems

  6/22/2026

  Control contamination in sourced ingredients with layered filtration: particle removal, bioburden control, and tank protection improve reliability, reduce risk, and supports consistent product quality.

• Monitor Cleanrooms Anytime, Anywhere

  8/4/2025

  Remotely monitor cleanroom environments with secure, real-time data access from any device, anywhere, helping to streamline operations and ensure compliance.

• Integration From Formulation Development To Manufacturing, Packaging

  2/27/2025

  Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.